We are live on
!
Find out more
HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
+7.32%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.65B
AUM Growth
–
Cap. Flow
+$1.64B
Cap. Flow
% of AUM
99.42%
Top 10 Holdings %
Top 10 Hldgs %
51.69%
Holding
47
New
47
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
+$200M |
| 2 |
Gilead Sciences
GILD
|
+$109M |
| 3 |
Intuitive Surgical
ISRG
|
+$91.7M |
| 4 |
ARTC
ARTHROCARE CORP
ARTC
|
+$77.4M |
| 5 |
WMGI
Wright Medical Group Inc
WMGI
|
+$67.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 70.8% |
| 2 | Financials | 4.43% |
| 3 | Consumer Staples | 3.77% |
| 4 | Technology | 0.79% |
| 5 | Real Estate | 0.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Celldex Therapeutics
CLDX
$2.99B
| $22.6M | 1.37% |
+96,667
| New | +$19M |
|
27
CorVel
CRVL
$3.06B
| $22.2M | 1.34% |
+2,270,766
| New | +$19.4M |
|
|
DVAX
28
DELISTED
Dynavax Technologies
DVAX
| $19.4M | 1.17% |
+1,760,000
| New | +$37.1M |
|
29
Jazz Pharmaceuticals
JAZZ
$15.9B
| $17.2M | 1.04% |
+250,000
| New | +$15.3M |
|
30
Incyte
INCY
$24.2B
| $17.1M | 1.03% |
+775,000
| New | +$16.9M |
|
|
WWAV
31
DELISTED
The WhiteWave Foods Company
WWAV
| $16.8M | 1.01% |
+1,030,966
| New | +$17.7M |
|
|
IPXL
32
DELISTED
Impax Laboratories, Inc.
IPXL
| $16.5M | 1% |
+826,300
| New | +$14.7M |
|
|
CYNO
33
DELISTED
Cynosure, Inc. Class A
CYNO
| $15.6M | 0.94% |
+600,000
| New | +$15M |
|
|
ACOR
34
DELISTED
Acorda Therapeutics
ACOR
| $13.3M | 0.8% |
+3,348
| New | +$13.8M |
|
|
AIRM
35
DELISTED
Air Methods Corp
AIRM
| $13.1M | 0.79% |
+385,400
| New | +$14.9M |
|
|
CMRX
36
DELISTED
Chimerix, Inc.
CMRX
| $11.7M | 0.71% |
+483,072
| New | +$10.1M |
|
37
Humana
HUM
$43.7B
| $10.5M | 0.64% |
+125,000
| New | +$9.87M |
|
38
Innoviva
INVA
$1.55B
| $8.62M | 0.52% |
+277,612
| New | +$7.45M |
|
|
CLVS
39
DELISTED
Clovis Oncology, Inc.
CLVS
| $8.37M | 0.51% |
+125,000
| New | +$5.62M |
|
|
TMH
40
DELISTED
Team Health Holdings Inc
TMH
| $8.21M | 0.5% |
+200,000
| New | +$7.7M |
|
|
AKRX
41
DELISTED
Akorn Inc
AKRX
| $8.11M | 0.49% |
+600,000
| New | +$8.48M |
|
|
AEGR
42
DELISTED
Aegerion Pharmaceuticals
AEGR
| $8.03M | 0.49% |
+126,700
| New | +$6.73M |
|
|
WWAV.B
43
DELISTED
THE WHITEWAVE FOODS COMPANY CLASS B COM STK
WWAV.B
| $7.15M | 0.43% |
+470,680
| New | +$7.73M |
|
44
Healthpeak Properties
DOC
$15.1B
| $2.03M | 0.12% |
+48,971
| New | +$2.23M |
|
45
Welltower
WELL
$169B
| $1.39M | 0.08% |
+20,700
| New | +$1.47M |
|
46
Cooper Companies
COO
$14.1B
| $905K | 0.05% |
+30,400
| New | +$854K |
|
|
UHT
47
Universal Health Realty Income Trust
UHT
$603M
| $612K | 0.04% |
+14,200
| New | +$728K |
|
Similar funds
IA
EPC
TCMV
SI
HCWM
PC
RF
AWM
HealthCor Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for HealthCor Management, which disclosed 47 positions worth $1.65B. Its ten largest holdings account for 52% of the portfolio.
Its largest position is Veradigm Inc. Common Stock: 14,900,000 shares worth $193M.
By sector, the portfolio is most concentrated in Healthcare at 71% of assets, followed by Financials and Consumer Staples.
- HealthCor Management's largest Q2 2013 buy was Veradigm Inc. Common Stock: 14,900,000 shares worth $193M.
- HealthCor Management's ten largest holdings make up 52% of its $1.65B portfolio in Q2 2013.
- HealthCor Management disclosed 47 positions in Q2 2013, its first 13F filing on record.
Based on HealthCor Management's 13F filing for Q2 2013, filed 14 Aug 2013.